Core Wealth Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Hold
2,000
0.45% 57
2026
Q1
$960K Hold
2,000
0.45% 55
2025
Q4
$1.12M Hold
2,000
0.51% 49
2025
Q3
$1.03M Hold
2,000
0.47% 50
2025
Q2
$628K Hold
2,000
0.32% 72
2025
Q1
$609K Hold
2,000
0.35% 71
2024
Q4
$664K Hold
2,000
0.38% 59
2024
Q3
$668K Hold
2,000
0.4% 61
2024
Q2
$824K Hold
2,000
0.56% 42
2024
Q1
$808K Hold
2,000
0.61% 39
2023
Q4
$613K Hold
2,000
0.5% 47
2023
Q3
$484K Hold
2,000
0.44% 51
2023
Q2
$480K Hold
2,000
0.44% 55
2023
Q1
$376K Buy
+2,000
New +$414K 0.38% 60

Other funds holding MEDP

Core Wealth Partners's MEDP Position: Q2 2026 in Review

Core Wealth Partners held its Medpace (MEDP) position steady in Q2 2026 at 2,000 shares worth $1.06M. The position accounts for 0.45% of the portfolio, ranked #57.

Core Wealth Partners first reported a position in MEDP in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.12M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Core Wealth Partners held 2,000 shares of Medpace worth $1.06M as of Q2 2026.
  • Core Wealth Partners left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.45% of Core Wealth Partners's portfolio in Q2 2026, its #57 holding.
  • Core Wealth Partners first reported a position in Medpace in Q1 2023 and has held it in 14 quarters since.
  • Core Wealth Partners's Medpace position peaked at $1.12M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.